Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response.

Chih-Hsuan Luan,Pin-Shuo Su,Chi-Jen Chu,Chung-Chi Lin,Chien-Wei Su,Shou-Dong Lee,Yuan-Jen Wang,Fa-Yauh Lee,Yi-Hsiang Huang,Ming-Chih Hou

Journal of the Chinese Medical Association : JCMA（2023）

引用 0|浏览10

暂无评分

摘要

Despite achieving viral clearance with DAAs, CHC patients still face a residual risk of de novo HCC. Establishing a risk stratification model based on independent variables could facilitate the prediction of future HCC development and enhance screening strategies.

查看译文

关键词

Advanced fibrosis, Chronic hepatitis C, Direct-acting anti-virals, Hepatocellular carcinoma, Risk stratification model, Sustained virological response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要